Operating margin · 2016–2025
Corcept Therapeutics operating margin
5.9%−71.0% · FY2025
Corcept Therapeutics (CORT) reported 5.9% in operating margin for fiscal 2025, −71.0% year on year.
| Fiscal year | Operating margin | Change | Filing |
|---|---|---|---|
| FY2025 | 5.9% | −71.0% | Derived |
| FY2024 | 20.3% | −8.8% | Derived |
| FY2023 | 22.2% | −20.7% | Derived |
| FY2022 | 28.0% | −17.6% | Derived |
| FY2021 | 34.0% | −6.1% | Derived |
| FY2020 | 36.2% | −0.5% | Derived |
| FY2019 | 36.4% | +2.2% | Derived |
| FY2018 | 35.6% | +7.3% | Derived |
| FY2017 | 33.2% | +165.2% | Derived |
| FY2016 | 12.5% | — | Derived |
Operating margin — Operating margin is operating income divided by revenue. Only companies with at least $1 billion in revenue are ranked here.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2016–2025 compound annual growth −8.0%
Calculated from two reported figures, so it has no single filing of its own.
Operating margin at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Corcept Therapeutics operating margin |url=https://companiesranked.com/en/company/corcept-therapeutics/operating-margin |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Corcept Therapeutics operating margin. CompaniesRanked. https://companiesranked.com/en/company/corcept-therapeutics/operating-marginBibTeX
@misc{companiesranked-en-company-corcept-therapeutics-operating-margin-2026,
author = {{CompaniesRanked}},
title = {{Corcept Therapeutics operating margin}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/corcept-therapeutics/operating-margin}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.